Viridian Therapeutics (VRDN)
(Delayed Data from NSDQ)
$12.88 USD
+0.18 (1.42%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $12.87 -0.01 (-0.08%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-1.07 | 0.00% |
Earnings Summary
For their last quarter, Viridian Therapeutics (VRDN) reported earnings of -$1.35 per share, missing the Zacks Consensus Estimate of -$1.08 per share. This reflects a negative earnings surprise of 25.00%. Look out for VRDN's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$1.07 per share, reflecting a year-over-year increase of 33.54%.
Earnings History
Price & Consensus
Zacks News for VRDN
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Tops Revenue Estimates
VRDN: What are Zacks experts saying now?
Zacks Private Portfolio Services